Description

The global life science tools and reagents market is set to increase by US$ 48.4 billion from 2022 to 2028, representing a compound annual growth rate (CAGR) of 7.2% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for life science tools and reagents. The global life science tools and reagents market is segmented on the basis of product type, application, and region. On the basis of product type, the global life science tools and reagents market has been segmented into life science tools, life science COVID-19 diagnostics products. By application, the global life science tools and reagents market has been segmented into animal models, bioinformatics, cell biology, epigenetics, genomics, imaging and microscopy, proteomics, stem cells, others. Among these, the genomics segment was accounted for the highest revenue generator in 2021. In terms of geography, the global life science tools and reagents market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global life science tools and reagents market is highly competitive. The key players in the life science tools and reagents market include Abcam plc, Abnova Corp., Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Bio-Techne Corp., Bruker Corp., Carl Zeiss Inc., Charles River Laboratories Inc., Danaher Corp., GE Healthcare, GenOway S.A., Hitachi High-Tech Group, Illumina Inc., JEOL Ltd., Labcorp Drug Development, Luminex Corporation, Merck KGaA (includes Sigma Aldrich), Novozymes Inc., Olympus Inc., Perkin Elmer Inc., Perkin Elmer Inc., Plus Therapeutics Inc., Qiagen N.V., Roche Holding AG, Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the life science tools and reagents market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

Report Scope

Product type: life science tools, life science COVID-19 diagnostics products
Application: animal models, bioinformatics, cell biology, epigenetics, genomics, imaging and microscopy, proteomics, stem cells, others
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028

Key Benefits for Stakeholders

– Get a comprehensive picture of the global life science tools and reagents market
– Pinpoint growth sectors and trends for investment

Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Life science tools and reagents market overview
Part 3. Market breakdown by product type
– Life science tools
– Life science COVID-19 diagnostics products
Part 4. Market breakdown by application
– Animal models
– Bioinformatics
– Cell biology
– Epigenetics
– Genomics
– Imaging and microscopy
– Proteomics
– Stem cells
– Others
Part 5. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 6. Key companies
– Abcam plc
– Abnova Corp.
– Agilent Technologies Inc.
– Becton, Dickinson and Company
– Bio-Rad Laboratories, Inc.
– Bio-Techne Corp.
– Bruker Corp.
– Carl Zeiss Inc.
– Charles River Laboratories Inc.
– Danaher Corp.
– GE Healthcare
– GenOway S.A.
– Hitachi High-Tech Group
– Illumina, Inc.
– JEOL Ltd.
– Labcorp Drug Development
– Luminex Corporation
– Merck KGaA (includes Sigma Aldrich)
– Novozymes Inc.
– Olympus Inc.
– Perkin Elmer Inc.
– Perkin Elmer Inc.
– Plus Therapeutics Inc.
– Qiagen N.V.
– Roche Holding AG
– Shimadzu Corporation
– Siemens Healthineers AG
– Thermo Fisher Scientific Inc.
– Waters Corporation
About StrategyHelix
Disclaimer